Form 4: Acrivon Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Katharine Peterson, Chief Accounting Officer of Acrivon Therapeutics, Inc., sold 101 shares of common stock on August 18, 2026 for $2.01 per share.
Summary
- Open-market sale: disposed of 101 Common Stock at $2.01 ($203) on August 18, 2026; holds 18,033 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $203 of stock on the open market.
Insider Transactions
Katharine Peterson — Officer (Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 101 | $2 | $203 | 18,033 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (101 shares) |
Keywords
insider transaction, Form 4, ACRV, Acrivon Therapeutics, Inc., bearish, Katharine Peterson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.